Copyright
©The Author(s) 2019.
World J Gastroenterol. Jul 14, 2019; 25(26): 3359-3369
Published online Jul 14, 2019. doi: 10.3748/wjg.v25.i26.3359
Published online Jul 14, 2019. doi: 10.3748/wjg.v25.i26.3359
Table 1 Current literature summary of aptamers for in vitro detection of liver cancer
First author | Year | Aptamer | Target | System for detection | Method for detection |
Hu et al[51] | 2017 | TLS11a | HepG2 cells | Bio-TLS11a and SA-FSNPs | Fluorescence Microscopy |
Wang et al[52] | 2016 | sLex-AP | CTCs | CTC-BioT Chip | Fluorescence Microscopy |
Joo et al[53] | 2017 | AFB1-Apt | AFB1 | FAM modified AFB1-Apt and GO | Fluorescence Microscopy |
Kaur et al[54] | 2019 | SL2-B | HepG2 cells | QDs labeled SL2-B | Fluorescence Microscopy |
Zhou et al[55] | 2019 | Slow-off aptamer (TD10); fast-off aptamer | DKK1 protein | 5′ amino C6 modified TD10-based ELISA; 5′ FAM labeled fast-off aptamer | ELISA (TD10); dot blot and flow cytometry (fast-off aptamer) |
- Citation: Zhang GQ, Zhong LP, Yang N, Zhao YX. Screening of aptamers and their potential application in targeted diagnosis and therapy of liver cancer. World J Gastroenterol 2019; 25(26): 3359-3369
- URL: https://www.wjgnet.com/1007-9327/full/v25/i26/3359.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i26.3359